Catalyst Pharmaceuticals, Inc. (CPRX)

NGM – Real vaqt narxi. Valyuta: USD

31.49

+31.49 (0.00%)

Bozor ochiq: Jul 14, 2026, 4:00 PM EDT

Kompaniya haqida

Catalyst Pharmaceuticals, Inc., tijorat bosqichidagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda kam uchraydigan kasalliklari bo'lgan bemorlar uchun dori vositalarini ishlab chiqish va tijoratlashtirishga qaratilgan. U lambert-eaton miyastenik sindromi (LEMS) bilan og'rigan bemorlarni davolash uchun Firdapse; fokal boshlanuvchi tutqanoqlarni, shuningdek tonik-klonik tutqanoqlarni davolash uchun ishlatiladigan postsinaptik ionotrop alfa-amino-3-gidroksi-5-metil-4-izoksazolpropion kislotasi glutamat retseptorining yangi, raqobatchi bo'lmagan selektiv antagonistini Fycompa; va Duchenne mushak distrofiyasini davolash uchun kortikosteroid bo'lgan AGAMREEni taklif etadi. Kompaniya BioMarin Pharmaceutical Inc. bilan litsenziyalash shartnomalariga; va jenerik Sabril planshetlarini ishlab chiqish va tijoratlashtirish bo'yicha Endo Ventures Limited bilan hamkorlik va litsenziyalash shartnomasiga ega. Catalyst Pharmaceuticals, Inc. 2002 yilda tashkil etilgan va Coral Gables, Florida shtatida joylashgan.

Asosiy rahbarlar

Ism	Lavozim
Dr. Preethi Sundaram Ph.D.	Chief Strategy Officer
Dr. Steven R. Miller Ph.D.	Executive VP, COO & Chief Scientific Officer
Dr. William T. Andrews FACP, M.D.	Chief Medical Officer
Mr. Brian Elsbernd J.D.	Chief Compliance Officer & Chief Legal Officer
Mr. Gregg Russo	Chief Human Resources Officer
Mr. Jeffrey Del Carmen	Executive VP & Chief Commercial Officer